The Vice Presidents at Denali Therapeutics are senior leaders responsible for guiding strategic initiatives across various functions, including investor relations, biometrics, European development, intellectual property and transactions, chemistry, manufacturing, and controls (CMC), and global product strategy and U.S. market access. They play a crucial role in advancing the company's mission to develop effective treatments for neurodegenerative diseases by leveraging their expertise and ensuring cross-functional alignment.
View all